Therefore, we hypothesized that inhibition of IRAK1 activity might attenuate macrophage activity and further improved the inflammatory response of SLE by reducing the secretion of macrophage inflammatory factors. This evidence concerns the gene IRAK1 and systemic lupus erythematosus.